Clinical Trial Update: Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and gastrointestinal effects of intravenous methylnaltrexone in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• Methylnaltrexone (methylnaltrexone)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Healthy Volunteers | Phase 2 | Status: COMPLETED